NYSE:MRT - MedEquities Realty Trust Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$11.03
+0.30 (1.20%)
Get New MedEquities Realty Trust Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MRT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MRT

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for MedEquities Realty Trust in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $11.03.

This chart shows the closing price for MRT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in MedEquities Realty Trust. This rating has held steady since December 2019, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/5/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/4/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/2/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/31/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/31/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/29/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/28/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/27/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/4/2019Raymond JamesDowngradeMarket PerformLow
1/3/2019B. RileyReiterated RatingBuy ➝ Neutral$10.50 ➝ $10.00Low
1/2/2019JPMorgan Chase & Co.UpgradeUnderweight ➝ NeutralHigh
1/2/2019JMP SecuritiesDowngradeMarket PerformHigh
11/20/2018Raymond JamesLower Price TargetOutperform ➝ Buy$12.00 ➝ $10.00High
11/13/2018B. RileyLower Price TargetBuy ➝ Buy$12.00 ➝ $11.00High
11/12/2018CitigroupUpgradeSell ➝ Neutral$9.00High
10/23/2018JMP SecuritiesSet Price TargetBuy$12.00Low
9/28/2018Cantor FitzgeraldReiterated RatingOverweight ➝ Neutral$12.00 ➝ $10.00High
9/14/2018CitigroupDowngradeNeutral ➝ Sell$10.00 ➝ $9.00High
8/12/2018Royal Bank of CanadaSet Price TargetHold$10.00Low
8/9/2018B. RileySet Price TargetBuy$12.00Medium
8/9/2018Canaccord GenuityLower Price TargetOverweight ➝ Overweight$13.00 ➝ $12.00Low
8/8/2018KeyCorpDowngradeOverweight ➝ Hold$12.00Medium
5/23/2018Royal Bank of CanadaReiterated RatingOutperform ➝ Sector Perform$12.00 ➝ $11.00Low
5/14/2018B. RileySet Price TargetBuy$13.00Medium
5/11/2018JMP SecuritiesSet Price TargetBuy$13.00Medium
4/16/2018KeyCorpLower Price TargetOverweight ➝ Overweight$13.00 ➝ $12.00Medium
3/1/2018CitigroupLower Price TargetNeutral ➝ Neutral$12.00 ➝ $10.00Low
2/22/2018B. RileySet Price TargetBuy ➝ Buy$14.00 ➝ $13.00High
2/21/2018Cantor FitzgeraldReiterated RatingBuy$14.00Medium
11/8/2017B. RileyReiterated RatingBuyN/A
11/1/2017B. RileyReiterated RatingBuyN/A
10/29/2017KeyCorpSet Price TargetBuy$13.00N/A
10/23/2017Capital One FinancialInitiated CoverageEqual Weight$13.00N/A
10/22/2017Capital One FinancialReiterated RatingEqual WeightN/A
9/26/2017KeyCorpReiterated RatingBuy$13.00Low
8/31/2017Cantor FitzgeraldInitiated CoverageOverweight$14.00Low
8/25/2017KeyCorpReiterated RatingBuy$13.00High
3/6/2017Royal Bank of CanadaReiterated RatingOutperform$13.00N/A
12/16/2016JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$12.50 ➝ $12.00N/A
11/14/2016KeyCorpInitiated CoverageOverweight$13.00N/A
11/9/2016FBR & Co.Reiterated RatingBuyN/A
10/24/2016Raymond JamesInitiated CoverageOutperform$13.00N/A
10/24/2016Royal Bank of CanadaInitiated CoverageOutperform$13.00N/A
10/24/2016JMP SecuritiesInitiated CoverageOutperform$13.00N/A
10/24/2016FBR & Co.Initiated CoverageOutperform$14.00N/A
10/24/2016JPMorgan Chase & Co.Initiated CoverageNeutral$13.00N/A
10/24/2016CitigroupInitiated CoverageNeutral$12.00N/A
(Data available from 9/28/2016 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/2/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/1/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/1/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/31/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/30/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/30/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/29/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/28/2021

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
MedEquities Realty Trust logo
MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios. MedEquities' strategy is to become an integral capital partner with high-quality and growth-oriented facility-based providers of healthcare services on a nationwide basis, primarily through net-leased real estate investment.
Read More

Today's Range

Now: $11.03
Low: $11.03
High: $11.03

50 Day Range

MA: $11.03
Low: $11.03
High: $11.03

52 Week Range

Now: $11.03
Low: $6.27
High: $11.85

Volume

N/A

Average Volume

483,321 shs

Market Capitalization

$351.20 million

P/E Ratio

9.76

Dividend Yield

3.81%

Beta

1.64

Frequently Asked Questions

What sell-side analysts currently cover shares of MedEquities Realty Trust?

The following Wall Street analysts have issued reports on MedEquities Realty Trust in the last year:
View the latest analyst ratings for MRT.

What is the current price target for MedEquities Realty Trust?

0 Wall Street analysts have set twelve-month price targets for MedEquities Realty Trust in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for MedEquities Realty Trust in the next year.
View the latest price targets for MRT.

What is the current consensus analyst rating for MedEquities Realty Trust?

MedEquities Realty Trust currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for MRT.

How do I contact MedEquities Realty Trust's investor relations team?

MedEquities Realty Trust's physical mailing address is 3100 WEST END AVENUE SUITE 1000, NASHVILLE TN, 37203. The financial services provider's listed phone number is 615-627-4710 and its investor relations email address is [email protected] The official website for MedEquities Realty Trust is www.medequities.com.